fr

CARMAT announces its judicial liquidation and delisting

CARMAT will benefit from the European SEED program that supports innovative therapy developers seeking reimbursement

Download

The patient who received a CARMAT bioprosthetic heart in Nantes on August 5, 2014 has been discharged home

Download

2015 financial agenda

Download

CARMAT secures its cash position by reaching milestone n°5 of its contract with Bpifrance, and receives €5.3m

Download

CARMAT wins the 2014 INPI Award in the "Patent" category

Download

2014 half-year results

Download

CARMAT is participating in the 28th EACTS Annual Meeting in Milan (Italy)

Download

Shareholder newsletter n°6

Download
Top of page